Evidence map›Paper›PMID 17202306›Full record

ArticleClinical and vaccine immunology : CVI2007

Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice.

Naima G Cortes-Perez, Sandrine Ah-Leung, Luis G Bermúdez-Humarán, Gérard Corthier, Jean-Michel Wal, Philippe Langella, Karine Adel-Patient

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Lactococcus lactis, a bacterium with probiotic functions and pathogenicity.World journal of microbiology & biotechnology · 2023
    Review
  3. Review
  4. Article
  5. Genetic Engineering ofFrontiers in microbiology · 2018
    Article
  6. Frontiers in immunology · 2017
    Review
  7. Recombinant InvasiveFrontiers in microbiology · 2017
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Nonallergen-specific treatments for food allergy.Current opinion in allergy and clinical immunology · 2012
    Review
  15. Strategies of mucosal immunotherapy for allergic diseases.Cellular & molecular immunology · 2011
    Review
  16. Review
  17. Article
  18. Food allergy.The Journal of clinical investigation · 2011
    Review
  19. Future therapies for food allergies.The Journal of allergy and clinical immunology · 2011
    Review
  20. [Use of lactic acid bacteria as mucosal vaccines].Revue francophone des laboratoires : RFL · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Naima G Cortes-PerezLaboratoire INRA d'Immuno-Allergie Alimentaire, DSV/SPI-Bâtiment 136, CEA de Saclay, 91191 Gif-sur-Yvette cedex, France.
Sandrine Ah-Leung
Luis G Bermúdez-Humarán
Gérard Corthier
Jean-Michel Wal
Philippe Langella
Karine Adel-Patient
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCEA Paris-Saclay · FRVirologie et Immunologie Moléculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Th1/Th2 balance deregulation toward a Th2 immune response plays a central role in allergy. We previously demonstrated that administration of recombinant Lactococcus lactis strains expressing bovine beta-lactoglobulin (BLG), a major cow's milk allergen, partially prevents mice from sensitization. In the present study, we aimed to improve this preventive effect by coadministration of L. lactis BLG and a second recombinant L. lactis strain producing biologically active interleukin-12 (IL-12). This L. lactis strain producing IL-12 was previously used to enhance the Th1 immune response in a tumoral murine model (L. G. Bermúdez-Humarán et al., J. Immunol. 175:7297-7302, 2005). A comparison of the administration of either BLG alone or BLG in the presence of IL-12 was conducted. A BLG-specific primary Th1 immune response was observed only after intranasal coadministration of both L. lactis BLG and IL-12-producing L. lactis, as demonstrated by the induction of serum-specific immunoglobulin G2a (IgG2a) concomitant with gamma interferon secretion by splenocytes, confirming the adjuvanticity of IL-12-producing L. lactis. Immunized mice were further sensitized by intraperitoneal administration of purified BLG, and the allergic reaction was elicited by intranasal challenge with purified BLG. Mice pretreated with BLG in either the presence or the absence of IL-12 were rendered completely tolerant to further allergic sensitization and elicitation. Pretreatment with either L. lactis BLG or L. lactis BLG and IL-12-producing L. lactis induces specific anti-BLG IgG2a production in serum and bronchoalveolar lavage (BAL) fluid. Although specific serum IgE was not affected by these pretreatments, the levels of eosinophilia and IL-5 secretion in BAL fluid were significantly reduced after BLG challenge in the groups pretreated with L. lactis BLG and L. lactis BLG-IL-12-producing L. lactis, demonstrating a decreased allergic reaction. Our data demonstrate for the first time (i) the induction of a protective Th1 response by the association of L. lactis BLG and IL-12-producing L. lactis which inhibits the elicitation of the allergic reaction to BLG in mice and (ii) the efficiency of intranasal administration of BLG for the induction of tolerance.

Indexed as

Administration, IntranasalAnimalsCattleFemaleImmunoglobulin GInterferon-gammaInterleukin-12Interleukin-4Lactococcus lactisLactoglobulinsMiceMice, Inbred BALB CMilk HypersensitivityVaccines, SyntheticImmunoglobulin GInterferon-gammaInterleukin-12Interleukin-4LactoglobulinsVaccines, Synthetic

Identifiers

PMID17202306
PMCPMC1828845
OpenAlexW2170551721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.